EP1383543A4 - Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebrales - Google Patents
Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebralesInfo
- Publication number
- EP1383543A4 EP1383543A4 EP02726668A EP02726668A EP1383543A4 EP 1383543 A4 EP1383543 A4 EP 1383543A4 EP 02726668 A EP02726668 A EP 02726668A EP 02726668 A EP02726668 A EP 02726668A EP 1383543 A4 EP1383543 A4 EP 1383543A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- visualization
- treatment
- brain tumors
- biomolecular targets
- biomolecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US816703 | 2001-03-23 | ||
US09/816,703 US6455026B1 (en) | 2001-03-23 | 2001-03-23 | Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors |
US983000 | 2001-10-17 | ||
US09/983,000 US20030118585A1 (en) | 2001-10-17 | 2001-10-17 | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
PCT/US2002/008992 WO2002076510A1 (fr) | 2001-03-23 | 2002-03-22 | Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebrales |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1383543A1 EP1383543A1 (fr) | 2004-01-28 |
EP1383543A4 true EP1383543A4 (fr) | 2006-06-21 |
Family
ID=27124105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02726668A Withdrawn EP1383543A4 (fr) | 2001-03-23 | 2002-03-22 | Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebrales |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1383543A4 (fr) |
JP (1) | JP2004537282A (fr) |
CA (1) | CA2439630A1 (fr) |
WO (1) | WO2002076510A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884619B2 (en) * | 2001-07-17 | 2005-04-26 | Yale University | Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
US7678769B2 (en) * | 2001-09-14 | 2010-03-16 | Compugen, Ltd. | Hepatocyte growth factor receptor splice variants and methods of using same |
US8501473B2 (en) | 2003-07-16 | 2013-08-06 | Evotec International Gmbh | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
WO2006029462A1 (fr) * | 2004-09-14 | 2006-03-23 | Autogen Research Pty Ltd | Molecule d'acide nucleique exprimee de façon differentielle dans un systeme de modele comportemental de souris et utilisations de ladite molecule |
CA2624535A1 (fr) | 2005-09-30 | 2007-04-05 | Compugen Ltd. | Variants d'epissure du recepteur du facteur de croissance des hepatocytes et methodes d'utilisation |
KR20110122881A (ko) * | 2006-04-07 | 2011-11-11 | 워너 칠콧 컴퍼니 엘엘씨 | 인간 단백질 타이로신 포스파타아제 베타(hptp베타)에 결합하는 항체 및 그의 용도 |
BRPI0814685A2 (pt) | 2007-07-10 | 2019-09-24 | Neurin Pharmaceuticals 1991 Ltd | variantes com splicing de cd44 em doenças neurodegenerativas |
GB201319446D0 (en) * | 2013-11-04 | 2013-12-18 | Immatics Biotechnologies Gmbh | Personalized immunotherapy against several neuronal and brain tumors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094629A2 (fr) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Determination de gene du cancer et recherche therapeutique utilisant des ensembles de genes signature |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9323884D0 (en) * | 1993-11-19 | 1994-01-05 | Eisai London Res Lab Ltd | Physiological modulation |
-
2002
- 2002-03-22 EP EP02726668A patent/EP1383543A4/fr not_active Withdrawn
- 2002-03-22 CA CA002439630A patent/CA2439630A1/fr not_active Abandoned
- 2002-03-22 JP JP2002575022A patent/JP2004537282A/ja active Pending
- 2002-03-22 WO PCT/US2002/008992 patent/WO2002076510A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094629A2 (fr) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Determination de gene du cancer et recherche therapeutique utilisant des ensembles de genes signature |
Non-Patent Citations (3)
Title |
---|
CANCER LETTERS, vol. 156, no. 2, 11 August 2000 (2000-08-11), pages 191 - 198, ISSN: 0304-3835 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 11 August 2000 (2000-08-11), KROES ROGER A ET AL: "The identification of novel therapeutic targets for the treatment of malignant brain tumors", XP002379786, Database accession no. PREV200000425434 * |
See also references of WO02076510A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1383543A1 (fr) | 2004-01-28 |
WO2002076510A1 (fr) | 2002-10-03 |
JP2004537282A (ja) | 2004-12-16 |
CA2439630A1 (fr) | 2002-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1495130A4 (fr) | Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebrales | |
EP1465997A4 (fr) | Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs | |
IL158273A0 (en) | Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer | |
PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
EP1641378A4 (fr) | Methodes et dispositifs de traitement de lesions cutanees | |
HK1076248A1 (en) | Use of rimexolone in the treatment of dry eye | |
AU2003291609A1 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
HU0103558D0 (en) | Pharmaceutical composition for the treatment of stroke and traumatic brain insury | |
HUP0401903A3 (en) | Improved use of et-743 in cancer thereapy | |
IL159887A0 (en) | Combination therapy for the treatment of cancer | |
AU2002346644A1 (en) | Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
GB0108671D0 (en) | Skin treatment | |
EP1383543A4 (fr) | Utilisation de cibles biomoleculaires dans le traitement et la visualisation de tumeurs cerebrales | |
IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
EP1385879A4 (fr) | Diagnostic et therapie des cancers du systeme reproducteur | |
AU2002340251A8 (en) | Use of mx gtpases in the prognosis and treatment of cancer | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
AU2002366195A8 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
AU2002346049A1 (en) | Coactivators in the diagnosis and treatment of breast cancer | |
AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
EP1409734A4 (fr) | Diagnostic et traitement du cancer | |
EP1328264A4 (fr) | Utilisation de phosphate d'estramustine dans le traitement de metastase osseuse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031023 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060524 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060831 |